Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Hollebecque

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
Current Opinion in Oncology|April 9, 2014
Implementing precision medicine initiatives in the clinic: a new paradigm in drug developmentAntoine Hollebecque, Christophe Massard, Jean-Charles Soria
Current Opinion in Oncology|March 14, 2012
Vascular disrupting agents: a delicate balance between efficacy and side effectsAntoine Hollebecque, Christophe Massard, Jean-Charles Soria
PPAR Research|April 15, 2009
Peroxisome proliferator-activated receptors in HBV-related infectionLaurent Dubuquoy, Alexandre Louvet, Antoine Hollebecque, et al.
Investigational New Drugs|December 18, 2013
Dysphonia induced by anti-angiogenic compoundsErika Saavedra, Antoine Hollebecque, Jean-Charles Soria, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2015
Systemic treatment of advanced hepatocellular carcinoma: from disillusions to new horizonsAntoine Hollebecque, David Malka, Charles Ferté, et al.
Expert Opinion on Investigational Drugs|March 1, 2021
Rare cancer, rare alteration: the case of NTRK fusions in biliary tract cancersAlice Boilève, Loïc Verlingue, Antoine Hollebecque, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2017
Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?Loic Verlingue, Antoine Hollebecque, Valérie Boige, et al.
Cancers|April 3, 2021
Immunotherapy in Advanced Biliary Tract CancersAlice Boilève, Marc Hilmi, Cristina Smolenschi, et al.
Hepatic Oncology|September 8, 2018
Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?Thierry de Baere, Lambros Tselikas, Frederic Deschamps, et al.
Bulletin Du Cancer|December 19, 2022
Marine Valéry, Baptiste Cervantes, Cristina Smolenschi, et al.
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
Current Opinion in Oncology|April 9, 2014
Implementing precision medicine initiatives in the clinic: a new paradigm in drug developmentAntoine Hollebecque, Christophe Massard, Jean-Charles Soria
Current Opinion in Oncology|March 14, 2012
Vascular disrupting agents: a delicate balance between efficacy and side effectsAntoine Hollebecque, Christophe Massard, Jean-Charles Soria
PPAR Research|April 15, 2009
Peroxisome proliferator-activated receptors in HBV-related infectionLaurent Dubuquoy, Alexandre Louvet, Antoine Hollebecque, et al.
Investigational New Drugs|December 18, 2013
Dysphonia induced by anti-angiogenic compoundsErika Saavedra, Antoine Hollebecque, Jean-Charles Soria, et al.
European Journal of Cancer (Oxford, England : 1990)|January 7, 2015
Systemic treatment of advanced hepatocellular carcinoma: from disillusions to new horizonsAntoine Hollebecque, David Malka, Charles Ferté, et al.
Expert Opinion on Investigational Drugs|March 1, 2021
Rare cancer, rare alteration: the case of NTRK fusions in biliary tract cancersAlice Boilève, Loïc Verlingue, Antoine Hollebecque, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2017
Matching genomic molecular aberrations with molecular targeted agents: Are biliary tract cancers an ideal playground?Loic Verlingue, Antoine Hollebecque, Valérie Boige, et al.
Cancers|April 3, 2021
Immunotherapy in Advanced Biliary Tract CancersAlice Boilève, Marc Hilmi, Cristina Smolenschi, et al.
Hepatic Oncology|September 8, 2018
Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?Thierry de Baere, Lambros Tselikas, Frederic Deschamps, et al.
Bulletin Du Cancer|December 19, 2022
Marine Valéry, Baptiste Cervantes, Cristina Smolenschi, et al.
Pageof 23